Aptar Appoints Global Finance and Operations Veteran Sarah Glickman to its Board of Directors
05 Septembre 2023 - 11:00PM
Business Wire
AptarGroup, Inc. (NYSE: ATR), a global leader in drug and
consumer product dosing, dispensing and protection technologies,
today announced that Sarah Glickman, an accomplished leader with
more than 30 years of global financial and operational experience,
has joined its Board of Directors.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20230905451175/en/
Sarah Glickman Joins Aptar’s Board of
Directors (Photo: Aptar)
“We are pleased to welcome Sarah Glickman to our Board of
Directors. Sarah’s extensive knowledge of all aspects of corporate
finance coupled with her global operational experience, including
in the pharmaceutical industry for companies like Novartis and
Bristol-Myers Squibb, makes her an important addition to Aptar’s
Board of Directors,” said Stephan B. Tanda, Aptar President and
CEO.
Sarah currently serves as the Chief Financial Officer and
Principal Accounting Officer for Criteo S.A., a global commerce
media company. Prior to joining Criteo, Sarah was the Acting Chief
Financial Officer at XPO, Inc. She also held global executive roles
at Novartis and Honeywell International and started her career at
PricewaterhouseCoopers. Since 2021, Sarah has served on the Board
of Directors and is Chair of the Audit Committee for 2seventy bio,
Inc., a biotech company (previously part of bluebird bio,
Inc.).
Candace Matthews, Chairperson of Aptar’s Board of Directors,
stated, “We are excited to welcome Sarah to Aptar’s Board of
Directors. Her strong operational and financial leadership roles in
large and complex global companies, such as Honeywell
International, will benefit Aptar and its shareholders. Sarah’s
appointment also underscores Aptar’s commitment to a
demographically and culturally diverse board; with her appointment
five out of the ten directors are women.”
On her appointment, Sarah Glickman said, “I am thrilled to join
Aptar’s Board of Directors. I look forward to leveraging my
experience and perspective to help the company continue to grow and
increase shareholder value while staying true to Aptar’s purpose of
transforming ideas into solutions that improve everyday life.”
Glickman is a U.S. CPA and a U.K. Fellow Chartered Accountant
with a degree in economics from the University of York,
England.
About Aptar
Aptar is a global leader in drug and consumer product dosing,
dispensing and protection technologies. Aptar’s innovative
solutions and services serve a variety of end markets including
pharmaceutical, beauty, personal care, home care, food and
beverage. Using insights, proprietary design, engineering and
science to create dispensing, dosing and protective technologies
for many of the world’s leading brands, Aptar in turn makes a
meaningful difference in the lives, looks, health and homes of
millions of patients and consumers around the world. Aptar is
headquartered in Crystal Lake, Illinois and has 13,500 dedicated
employees in 20 countries. For more information, visit
www.aptar.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230905451175/en/
Investor Relations Contact:
Mary Skafidas mary.skafidas@aptar.com 347-351-6407 Media Contact: Katie Reardon
katie.reardon@aptar.com 815-479-5671
AptarGroup (NYSE:ATR)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
AptarGroup (NYSE:ATR)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024